期刊文献+

补肾益精法中药复方对硬皮病小鼠皮肤纤维化的影响 被引量:4

Effect of Bushen Yijing Formula on Dermal Fibrosis in Scleroderma Model Mice
原文传递
导出
摘要 目的:研究补肾益精法中药复方对硬皮病小鼠皮肤纤维化表型的影响。方法:使用博来霉素诱导建立硬皮病小鼠模型,分别采用补肾益精法中药复方(中药复方组)、生理盐水(模型组)处理硬皮病模型小鼠,共3周,并设正常对照组。HE染色观察皮肤病理改变;使用实时定量逆转录-聚合酶链反应(RT-PCR)技术,测定各组小鼠I型胶原α2(COLⅠα2)基因表达情况。结果:成功建立硬皮病小鼠模型,皮肤病理HE染色显示,中药复方组小鼠皮肤纤维化有不同程度改善。模型组小鼠COLⅠα2基因表达较正常对照组高(P<0.01);经补肾益精法处理后,中药复方组小鼠COLⅠα2基因表达减少,与正常对照组比较,差异无显著性意义(P>0.05)。结论:补肾益精法中药复方可改善硬皮病模型小鼠皮肤纤维化程度。 Objective: To study the effect of Bushen Yijing formula, which has the action of tonifying kidney and nourishing essence, on dermal fibrosis in sc)eroderma model mice. Methods: Rat models of scleroderma were induced by bleomycin, and then were treated with Bushen Yijing formula or normal saline for three weeks. At the same time, normal control group was set. The pathological change of mice skin was observed by HE staining method, and the expression of collagen 1α 2(COL 1α 2) was detected by real-time quantitative reverse transcription polymerase chain reaction(RT-PCR). Results. Animal models of scleroderma were successfully established. The results of HE staining showed that dermal fibrosis of Bushen Yijing formula group was improved. COL 1α2 expression level in the model group was higher than that in the normal control group(P 〈 0.01), and was decreased in Bushen Yijing formula group after treatment (P 〉 0.05 compared with that in the normal control group). Conclusion: Bushen Yijing formula can relief dermal fibrosis in scleroderma model mice.
出处 《新中医》 CAS 2012年第6期149-151,共3页 New Chinese Medicine
基金 国家自然科学基金项目(编号:81102599) 广东省自然科学基金项目(编号:10451040701005294) 广东省科学技术厅项目(编号:2010B031600050)
关键词 硬皮病 补肾益精法 皮肤纤维化 动物实验 小鼠 Scleroderma Bushen Yijing Formula Dermal Fibrosis Animal Experiment Mic
  • 相关文献

参考文献7

  • 1邓铁涛.肺脾肾相关辨治硬皮病[J].中国中医药现代远程教育,2004,2(6):15-16. 被引量:27
  • 2郑 洪.邓铁涛教授治疗硬皮病验案2则[J].新中医,2002,34(5):10-10. 被引量:16
  • 3齐庆,李东海,查旭山,毛越苹,罗益金,李勇.补肾益精法对硬皮病成纤维细胞表型的影响及其表观遗传学意义[J].新中医,2011,43(2):134-136. 被引量:12
  • 4Abraham D. J. , J. Varga. Scleroderma: from cell and molecular mechanisms to disease models [J]. Trends lmmunol, 2005, 26(11): 587-595.
  • 5Yamamoto T, Takagawa model of sclerotic skin. I S, Katayamal, etal. Animal Local injections of bleomycin induce sclerotic skin mimicking scleroderma[J]. J Invest Dermatol, 1999, 112(4): 456~-462.
  • 6Bhattacharyya S. , J. Wei J, Varga J. Understand- ing fibrosis in systemic sclerosis= shifting paradigms, emerging opportunities [J]. Nat Rev Rheu- matol, 2011, 8(1) : 42-54.
  • 7Qi Q, Guo Q, Tan G, et al. Predictors of the sclero- derma phenotype in fibroblasts from systemic sclerosis patients[J]. J EurAcad Dermatol Venereol, 2009, 23 (2): 160-168.

二级参考文献6

共引文献41

同被引文献69

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部